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Abstract
Introduction Epidemiological studies of rheumatic diseases
have been conducted during the past 20 years in China. The aim
of this study was to clarify prevalence rates of common
rheumatic diseases in China.
Methods Relevant reports of population-based surveys
conducted from 1980 to 2006 were retrieved. Studies using the
World Health Organization-International League of Associations
for Rheumatology COPCORD (Community Oriented Program
for Control of Rheumatic Diseases) protocol and those that did
not employ this protocol but were published in recognized
journals were identified and analyzed.
Results Thirty-eight surveys including 241,169 adults from 25
provinces/cities were pooled for analysis. The prevalence of
rheumatic complaints ranged from 11.6% to 46.4%, varying by
locality, study protocol and age of the people surveyed.
Prevalence of symptomatic osteoarthritis (OA) varied from 5.1%
to 20.8%, with common sites of involvement being the lumbar
spine, knee joint and cervical spine. Compared with rates of
radiographic and symptomatic knee OA in the USA, elderly men
in Beijing exhibited similar prevalence rates and elderly women
exhibited a higher prevalence. The prevalence of hip OA and
hand OA was much lower in Chinese than in Caucasian
populations, but both kinds of OA were more common in coal
miners. The prevalence of ankylosing spondylitis ranged from
0.2% to 0.54% among Han ethnic Chinese and were lower
among mixed ethnic populations. The prevalence of psoriatic
arthritis ranged from 0.01% to 0.1%, and that of reactive arthritis
was 0.02%; undifferentiated spondyloarthropathy was identified
in 0.64% to 1.2% of the individuals included in the surveys. The
prevalence of rheumatoid arthritis (RA) ranged from 0.2% to
0.93%, with the highest rate being reported from a Taiwan
urban area. In mainland China there were no significant
differences in prevalence of RA between the northern and
southern parts of China, or between different ethnic groups. The
prevalence of hyperuricemia increased after the 1980s. The
prevalence of gout was found to have increased in recent
decades from 0.15% to 1.98%, apart from in the Taiwan
aborigines, among whom the highest prevalence rate of 11.7%
was recorded. The prevalence of primary Sjögren's syndrome in
Beijing was 0.77% by the Copenhagen criteria and 0.33% by
the San Diego criteria. The prevalence of soft tissue rheumatism
was 2.5% to 5.7%. Fibromyalgia was seldom observed in China.
Conclusion Rheumatic diseases are common in China. The
prevalence of rheumatic complaints varied with the locality
surveyed. The prevalence of OA is comparable with that in
Western countries but varies in terms of joint involvement. The
prevalence of ankylosing spondylitis is similar to that in
Caucasians. Except in Taiwan, the prevalence of RA in China is
lower than that in developed countries. The prevalence of
hyperuricemia and gout increased after the 1980s, but it
remains lower than that in developed countries. More studies
are required to evaluate prevalence rates among minority groups
in the west and northwest parts of China, and further study is
needed to address fibromyalgia in China.
APLAR = Asia Pacific League of Associations for Rheumatology; AS = ankylosing spondylitis; COPCORD = Community Oriented Program for Con-
trol of Rheumatic Diseases; ILAR = International League of Associations for Rheumatology; OA = osteoarthritis; RA = rheumatoid arthritis; SLE = 
systemic lupus erythematosus; SpA = spondyloarthropathy; uSpA = undifferentiated spondyloarthropathy; WHO = World Health Organization.Arthritis Research & Therapy    Vol 10 No 1    Zeng et al.
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Introduction
Rheumatology is a relatively new subspecialty of medicine in
China. The first rheumatology unit in China was established in
1980 in the Peking Union Medical College Hospital. Before
that, little was known about the epidemiology of rheumatic dis-
eases in China.
Initiated by International League of Associations for Rheuma-
tology (ILAR) and its then president Professor EP Engleman,
and the president of the Chinese Association of Rheumatol-
ogy, Professor NZ Zhang, a collaborative study of the epidemi-
ology of rheumatic diseases in China was began in 1984 [1,2].
Subsequently, the Community Oriented Program for Control
of Rheumatic Diseases (COPCORD) program was proposed
by the World Health Organization (WHO), ILAR and the Asia
Pacific League of Associations for Rheumatology (APLAR)
[3], and many other surveys were conducted either in cooper-
ation with developed countries such as the USA [4] or by Chi-
nese experts alone. This report reviews the epidemiology of
rheumatic disease in China.
Materials and methods
Reports of population studies relating to the epidemiology of
rheumatic diseases from 1980 to 2006 were screened manu-
ally and by electronic searches of the Chinese National Knowl-
edge Infrastructure (1980 to 2006), English Medical Current
Content (1994 to 2006), Medline (1980 to 2006) and Pub
Med (1980 to 2006). The databases was searched using the
following search terms: rheumatic disease, rheumatism, rheu-
matic complaints, osteoarthritis, spondyloarthropathy, ankylos-
ing spondylitis, psoriatic arthritis, reactive arthritis, Reiter
syndrome, inflammatory bowel disease arthritis, rheumatoid
arthritis, hyperuricemia, gout, systemic lupus erythematosus,
primary Sjögren's syndrome, soft tissue rheumatism, fibromy-
algia, and epidemiology, China. All of the abstracts were
reviewed and relevant reports identified. The findings are pre-
sented in seven sections: rheumatic complaints; osteoarthritis
(OA); ankylosing spondylitis (AS) and other forms of spondy-
loarthropathy (SpA); rheumatoid arthritis (RA); hyperuricemia;
gout; and other rheumatic diseases. We included only popula-
tion-based surveys that used the ILAR-China or COPCORD
protocols, or other methods (including medical interview,
physical examination and laboratory/radiographic examination)
employing generally accepted diagnostic criteria, and were
published in recognized journals. These reports were
extracted and pooled for analysis.
Diagnostic criteria
The diagnosis of RA and systemic lupus erythematosus (SLE)
was made according to the American College of Rheumatol-
ogy (ACR) criteria available at the time of the study. AS was
diagnosed using the New York criteria or the Modified New
York criteria, and SpA was identified using the European
Spondyloarthropathy Study Group criteria or the Amor criteria.
OA was diagnosed on the basis of symptoms plus radio-
graphic features, or physical findings and radiographs, or ACR
classification criteria (for hand, knee, and hip OA). Hyperuri-
caemia was defined as serum uric acid above 7.0 mg/dl in
men and above 6.0 mg/dl in women. Gout was diagnosed
using the 1977 ACR criteria.
Results
More than 500 articles were identified, of which 38 surveys [3-
41], involving 241,169 individuals from rural or urban areas,
fulfilled the requirements for inclusion in this study (Table 1).
Distribution of study locations
Thirty-eight surveys were analyzed. These were conducted in
25 provinces/cities, covering an area from northeast (Hei-
longjiang) to southeast (Hong Kong), and from northwest
(Ningxia) to east (Taiwan) of China (Figure 1).
Rheumatic complaints
The prevalence of rheumatic complaints, as reported in 13 sur-
veys [3,9,12,15,18,19,23,28,30,] that included 40,635 adult
in seven provinces/cities, varied from 11.6% to 46.4% (Table
2). These complaints were more prevalent in women than in
men, were more frequently observed in elderly than in young
individuals, and were more common in the north than in the
south. In the Shantou area there has been an increase in prev-
alence of rheumatic complaints during the past decade. The
rise in prevalence with latitude previously described [42]
receives support from the study findings evaluated here.
Figure 1
Targeted areas of the epidemiological study in China Targeted areas of the epidemiological study in China. The red circles 
indicate the locations of surveys of common rheumatic diseases. The 
yellow circles indicate the locations of hand OA surveys. 1, Hei-
longjiang; 2, Jilin; 3, Beijing; 4, Shandong; 5, Hebei; 6, Taiyuan; 7, 
Ningxia; 8, Shanghai; 9, Nanjing; 10, Taiwan; 11, Shantou; 12, 
Guangzhou; 13, Hong Kong.Available online http://arthritis-research.com/content/10/1/R17
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Table 1
List of 38 reports on common rheumatic diseases in China between 1974 and 2006
Site of survey [ref.] Location Age (Years) Time Method Number Focus
Male Female Total
Taiwan [4] Rural island ≥17 1974 Other 2,728 2,901 5,629 RA and AS
4 cities [5] Urban ≥20 1980 Other 267 235 502 SUA
Changchun [6] Factory ≥20a,b 1980 Other 27,272 8,825 36,097 RA and AS
Shanghai [7] Textile factory ≥18c 1984 Other 12,374 20,294 32,668 SLE
Shantou [8] Rural/urban ≥16 1985 Other 5,632 5,015 10,647 AS
Beijing [9] Rural ≥20 1987 ILAR 2,090 2,102 4,192 Common RD
Shantou [9] Rural ≥20 1987 COPCORD 2,384 2,673 5,057 Common RD
Hebei [10] Coal mine ≥16b 1988 Other 892 108 1,000 OA
Beijing [11] Urban 40 to 58 1988 Other 1,062 951 2,013 SUA
Beijing [11] Rural 40 to 58 1988 Other 558 949 1,507 SUA
Heilongjiang [12] Mountain ≥18a 1989 Other 1,224 1,087 2,311 Common RD
Guangzhou [13] Urban/rural 21 to 40 1989 Other 12,102 13,590 25,692 SLE
Ningxia [14] Highland ≥18d 1990 ILAR 5,143 5,277 10,420 Common RD
Shanghai [3] Urban ≥16 1992 COPCORD 914 1,096 2,010 Common RD
Shantou [15–17] Urban ≥16 1992 COPCORD 910 812 1,722 OA, BMD and gout
Hong Kong [18] Urban ≥16 1992 Other 898 1,090 1,988 RA
Taiwan [19] Urban ≥20 1992 Other 1,534 1,466 3,000 Common RD
Taiwan [19] Suburban ≥20 1992 Other 1,477 1,523 3,000 Common RD
Taiwan [19] Rural ≥20 1992 Other 1,555 1,443 2,998 Common RD
Beijing [20] Rural ≥16c 1994 Other 653 1,410 2,063 Knee OA
Beijing [21] Suburban ≥16c 1994 Other 611 1,359 2,066 pSS
Taiwan [22] Mountain ≥18e 1994 Other 145 197 342 SUA and gout
Shantou [23] Urban ≥16 1995 COPCORD 985 1,055 2,040 Common RD
Taiwan [24] Island ≥19 1996 Other 2,754 2,953 5,707 SUA and gout
Shandong [25] Rural ≥16 1996 ILAR 2,695 2,360 5,055 RA and AS
Shanghai [26] Urban ≥15 1997 COPCORD 913 1,124 2,037 SUA and gout
Shandong [27] Coast ≥20 1997 Other 8,449 8,595 17,044 Common RD
Shanghai [28] Urban ≥16 1998 COPCORD 3,190 3,394 6,584 Common RD
Shantou [29,30] Suburban ≥16 1999 COPCORD 975 1,054 2,029 SpA and gout
Beijing [31] Urban ≥16 1999 COPCORD 1,025 957 1,982 SpA
Beijing [32] Urban ≥60 2000 Other 614 878 1,492 Hip OA
Beijing [33] Urban ≥60 2000 Other 1,004 1,503 2,507 Hand OA
Beijing [34] Urban ≥60 2000 Other 730 1,051 1,781 Knee OA
Northeast [35] 15 Provincesf 17 to 40g 2000 COPCORD 20,068 0 20,068 AS
Qingdao [36] Urban ≥20 2002 Other 720 1,303 2,023 SUA
Nanjing [37] Urban ≥20 2003 Other 3,849 4,039 7,888 SUA and gout
Shanghai [38] Urban ≥40 2003 COPCORD 894 1,199 2,093 Knee OA
Taiyuan [39–41] Urban ≥16 2004 COPCORD 1,858 2,057 3,915 Common RD
All mentions of 'OA' in this table refer to symptomatic osteoarthritis (OA). aHan and Manchu ethnic. bMale>Female. cMale<Female. dHan and 
Muslim ethnic. eAborigines. f11 ethnic. gAll male. AS, ankylosing spondylitis; BMD, bone mineral density; COPCORD, Community Oriented 
Program for Control of Rheumatic Diseases; F, female; ILAR, International League of Associations for Rheumatology; M, male; pSS, primary 
Sjögren's syndrome; RA, rheumatoid arthritis; RD, rheumatic diseases; SLE, systemic lupus erythematosus; SUA, serum uric acid; SpA, 
spondyloarthropathy.Arthritis Research & Therapy    Vol 10 No 1    Zeng et al.
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Table 2
Rheumatic complaints in general populations
Site of survey [ref.] Location Age (Years) Latitude Time Number Prevalence (%)
Male Female Total Male Female Total
Heilongjiang [12] Rural ≥18 46 1989 1,224 1,087 2,311 47 46 46.4
Beijing [9] Rural ≥20 40 1987 2,090 2,102 4,192 33.4 47.1 40.3
Taiyuan [41] Urban ≥16 38 2004 1,858 2,057 3,915 15.23 20.89 18.4
Shanghai [3] Urban ≥16 32 1992 914 1,096 2,010 16.9 30.5 24.3
Shanghai [28] Urban ≥16 32 1998 3,190 3,394 6,584 11 18.7 13.3
Taiwan [19] Urban ≥20 25 1992 1,534 1,466 3,000 22 31 26.3
Taiwan [19] Suburban ≥20 25 1992 1,477 1,523 3,000 14.5 22.5 18.4
Taiwan [19] Rural ≥20 25 1992 1,555 1,443 2,998 17 32 24.3
Shantou [9] Rural ≥20 23 1987 2,384 2,673 5,057 8.9 14 11.6
Hong Kong [18] Urban ≥16 22 1992 898 1,090 1,988 9.5 15.8 13.0
Shantou [15] Urban ≥16 23 1992 910 812 1,722 11.8 13.3 12.5
Shantou [23] Urban ≥16 23 1995 985 1,055 2,040 12.3 21 18.1
Shantou [30] Suburban ≥16 23 1999 863 955 1,818 15.9 23.1 19.8
Table 3
Prevalence of symptomatic osteoarthritis in China
Site of survey
[ref.]
Location Age
(Years)
Time Number Prevalence (%)
Total Knee Lumbar Cervical Shoulder Elbow Hand Feet Ankle Hip
Hebei [10] Coal mine ≥16a 1988 1,000 20.8 1.5 12.9 1.4 1.3 0.50 0.30 0.10 2.0
Taiyuan [39] Urban ≥16 2004 3,915 11.15 7.57 3.60 3.54 0.80 0.03
Shantou [16] Urban ≥16 1992 1,722 8.3 1.3 6.0 4.5 0.06 0 0.1 0.3 0.15
Shantou [23] Urban ≥16 1995 2,040 10.8 3.2 7.6 1.8 0.2 0.4 0.4 0.1 0.3 0.15
Shanghai [3] Urban ≥16 1992 2,010 13.0
Taiwan [19] Urban ≥20 1992 3,000 5.1
Taiwan [19] Suburban ≥20 1992 3,000 5.8
Taiwan [19] Rural ≥20 1992 2,998 6.3
Beijing [20] Rural ≥16 1994 2,063 9.6
Beijing [32] Urban ≥60 2000 1,492 0.07
Beijing [34] Urban ≥60 2001 1,781 11.1
Shanghai [38] Urban ≥40 2003 2,093 7.2
Beijing [33] Urban ≥60 2001 2,507 M 3.0/ 
F 5.8
aMale (M) > Female (F).Available online http://arthritis-research.com/content/10/1/R17
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Symptomatic osteoarthritis
Thirteen surveys involving 29,621 adult people from six
regions reported on the prevalence of symptomatic OA
[3,10,16,19,20,23,32-34,38,39], which ranged from 5.1% to
20.8% (Table 3). The lowest rate was in a urban area of Tai-
wan [19], and the highest rate was reported in a survey of coal
miners in Handan of Hebei province [10].
The most common sites of OA in these reports were lumbar
spine, knee joints and cervical spine. The lowest prevalence of
lumbar OA (3.6%) was identified in an urban area of Taiyuan
[39], and the highest rate (12.9%) in the population of coal
miners [10]. Regarding the prevalence of knee OA, the lowest
rate (1.3%) was identified in a Shantou school population
[16], and the highest (11.1%) in a Beijing elderly urban popu-
lation [34]. The lowest prevalence of cervical OA (1.4%) was
identified in the coal miners [10], and the highest (4.5%) was
reported from the Shantou school population [16]. Apart from
these common sites of OA involvement, the prevalence rates
of hip OA and elbow OA in the coal miner population were
2.0% and 1.3% [10]; the rates of hand OA among Beijing res-
idents aged 60 years or older were 3.0% and 5.8% in men and
women, respectively [33]. OA in other sites such as shoulder,
elbow, hand, feet, ankle and hip were rarely observed.
Ankylosing spondylitis and the other forms of 
spondyloarthropathy
Seventeen surveys, including 120,451 adults from 12 prov-
inces/cities, reported on the prevalence of AS
[3,4,6,8,9,12,14,19,23,25,30,31,35,40] (Table 4). Fourteen
of these 17 surveys were conducted in Han ethnic popula-
tions, and the prevalence was 0.2% to 0.54%. The other three
surveys were conducted in mixed ethnic populations in Ningxia
(mainly of Muslim and Han) [14], Heilongjiang (Manchu and
Han) [12], and Changchun (Manchu and Han) [6], and the
prevalence rates were only 0.10%, 0.09% and 0.06%,
respectively. Nevertheless, a rate of 0.24% was reported from
a survey conducted in 20,068 male soldiers aged 17 to 40
years and selected from 11 ethnic origins [35].
The prevalence of PsA was 0.01% to 0.1% [6,25,30,31,40],
reactive arthritis 0.02% [25], and undifferentiated spondyloar-
thropathy (uSpA) 0.64% to 1.2% [30,31,40]. No case of
inflammatory bowel disease arthritis was reported.
Table 4
Prevalence of spondyloarthropathy in China
Site of survey [ref.] Location Age (Years) Ethnic Time Number Prevalence (%)
AS PsA ReA uSpA
Taiwan [4] Island ≥17 Han 1974 5,629 0.2
Beijing [9] Rural ≥20 Han 1987 4,192 0.26
Beijing [31] Urban ≥16 Han 1999 1,982 0.3 0.10 1.21
Taiyuan [40] Urban ≥16 Han 2004 3,915 0.2 0.05 0.64
Shandong [25] Rural ≥16 Han 1996 5,055 0.22 0.04 0.02
Shanghai [3] Urban ≥16 Han 1992 2,010 0.20
Taiwan [19] Urban ≥20 Han 1992 3,000 0.4
Taiwan [19] Suburban ≥20 Han 1992 3,000 0.19
Taiwan [19] Rural ≥20 Han 1992 2,998 0.54
Shantou [8] Rural ≥16 Han 1985 10,647 0.20
Shantou [9] Rural ≥20 Han 1987 5,058 0.26
Shantou [23] Urban ≥16 Han 1995 2,040 0.2
Shantou [30] Suburban ≥16 Han 1999 2,029 0.3 0.05 1.0
Military [35] 15 provinces 17 to 40a 11 ethnics 2000 20,068 0.24
Heilongjiang [12] Mountain ≥18 H and Mac 1989 2,311 0.09
Changchun [6] Factory ≥20b H and Mac 1980 36,097 0.06 0.01
Ningxia [14] Highland ≥18 H and Mud 1990 10,420 0.10
aAll male. bMale > female. cHan and Manchu. dHan and Muslin. AS, ankylosing spondylitis; PsA, psoriatic arthritis; ReA, reactive arthritis; uSpA, 
undifferentiated spondyloarthropathy.Arthritis Research & Therapy    Vol 10 No 1    Zeng et al.
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Frequency of HLA-B27
The frequency of HLA-B27 positive status in the Han ethnic
general population ranged from 3.6% to 5.7% [8,43-46]. The
frequency of HLA-B27  positive status in patients with AS
ranged from 90.6% to 93.6% [8,47,48]. At least eight
subtypes of HLA-B27 have been identified. The most common
subtypes were B2704 and B2705 [49-52]. No data on minor-
ity ethnic populations have been reported.
Family surveys of HLA-B27 positive AS revealed that about
half of first-degree relatives were HLA-B27 positive, among
whom the likelihood of developing AS was 50% [8,53,54].
Rheumatoid arthritis
Fifteen surveys from 10 provinces/cities, involving 94,297
adults, reported on the prevalence of RA (Table 5)
[3,4,6,9,12,14,18,19,23,25,28,41]. In mainland China the
prevalence ranged from 0.2% to 0.37%, and no significant dif-
ference was noted between north and south or between differ-
ent ethnic groups. In the Taiwan Island [19], a higher
prevalence of RA of 0.93% was reported from an urban area,
but in a rural area it was 0.26%, similar to that reported from
the mainland.
Hyperuricaemia and gout
During the early 1980s, the prevalence of hyperuricaemia
(Table 6) was only 1.4% in males and 1.3% in females in Bei-
jing, Shanghai, Hangzhou and Guangzhou [5]. In 1987 to
1988, however, the corresponding figures rose to 15.4% and
11.3% in Beijing [11] and 14.2% and 7.1% in Shanghai. In
mainland China, the highest prevalence was reported from
Qingdao [36], with rates of 32.1% in men and 21.8% in
women. Nevertheless, these rates were much lower than
those reported in Taiwan aborigines, at 53.8% in men and
30.7% in women [22].
Since 1992 the prevalence of primary gout has been reported
in 14 surveys [3,17,19,22-24,26,28,29,36,37,41] in 11 areas
involving 45,084 adults (Table 6). In mainland China, it ranged
from 0.15% to 0.67% in Han Chinese. The prevalence was
high in Taiwan aborigines [22], at 11.7%. In contrast, the prev-
alence of gout in a Taiwan rural area Han ethnic population
survey [19] was only 0.16%, similar to that reported in main-
land China.
The prevalence rates of primary gout in the Shantou area in
1992, 1995 and 1999 were 0.17%, 0.15% and 0.26%,
respectively [29], which indicates a trend toward increased
prevalence in the 1990s. Yang and coworkers [55] analyzed
changes in incidence of primary gout in 21 hospitals situated
throughout northern to southern China during the period from
1979 to 1993; in all cases they found a trend toward
increased incidence, which was more evident in southern cit-
ies. This was in accordance with findings in Shanghai; in the
latter, although no case of gout was found in the survey con-
ducted in the 1980s, the prevalence has been more than 0.2%
since 1992.
Table 5
Prevalence of rheumatoid arthritis in China
Site of survey [ref.] Location Age (Years) Ethnic Time Number Prevalence (%)
Taiwan [4] Rural island ≥17 Han 1974 5,629 0.3
Beijing [9] Rural ≥20 Han 1987 4,192 0.34
Taiyuan [41] Urban ≥16 Han 2004 3,915 0.28
Shandong [25] Rural ≥16 Han 1996 5,055 0.36
Shanghai [3] Urban ≥16 Han 1992 2,010 0.2
Shanghai [28] Urban ≥16 Han 1998 6,584 0.28
Hong Kong [18] Urban ≥16 Han 1992 1,988 0.35
Shantou [9] Rural ≥20 Han 1987 5,058 0.32
Shantou [23] Urban ≥16 Han 1995 2,040 0.2
Taiwan [19] Urban ≥20 Han 1994 3,000 0.93
Taiwan [19] Suburban ≥20 Han 1994 3,000 0.78
Taiwan [19] Rural ≥20 Han 1994 2,998 0.26
Heilongjiang [12] Mountain ≥18 H and Maa 1989 2,311 0.50
Changchun [6] Factory ≥20 H and Maa 1980 36,097 0.32
Ningxia [14] Highland ≥18 H and Mub 1990 10,420 0.36
aHan and Manchu. bHan and Muslin.Available online http://arthritis-research.com/content/10/1/R17
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Systemic lupus erythematosus
Three surveys were carried out in 1984, 1989 and 1997 in
Shanghai [7], Guangzhou [13] and Shandong [27]. The sur-
veyed population sizes were 32,668, 25,692 and 17,044, and
the obtained prevalence rates of SLE were 0.07% (70.1/
100,000), 0.03% (31.1/100,000) and 0.05% (46.5/
100,000), respectively.
Soft tissue rheumatism
Soft tissue rheumatism was surveyed in Shantou, Guangdong
province, and Taiyuan, Shanxi province in 2005 [41]. The prev-
alence in Shantou was 5.7%, which is significantly higher than
that in Taiyuan (2.5%). Rotator cuff tendinitis, adhesive capsu-
litis (frozen shoulder) and lateral epicondylitis (tennis elbow)
were the most frequent soft tissue rheumatism diagnoses, with
prevalence rates of 0.8%, 0.5% and 0.6%, respectively. The
prevalence was significantly higher in women than in men
(4.7% versus 2.6%) and exhibited an increasing trend with
age, particularly in the 35 to 54 years age group. Fibromyalgia
was seldom seen in both these areas; only two cases were
found in Shantou (2,350 people) and one in Taiyuan (3,915
people).
Primary Sjögren's syndrome
In 1995 Zhang and coworkers [21] reported a population sur-
vey of 2,066 adults in Beijing, which indicated the prevalence
of primary Sjögren's syndrome to be 0.77% by the Copenha-
gen classification criteria and 0.33% by the San Diego classi-
fication criteria.
Discussion
During the past two decades many studies of the epidemiol-
ogy of rheumatic diseases in China have been conducted. The
authors fully appreciate the difficulties in summarizing all of
these reports, because most of them were not done in a uni-
form or systematic way. Because of these issues, only 38 sur-
veys – including 241,169 adults from 25 provinces/cities –
were pooled and analyzed. Evidently, the surveyed populations
were living under different environment conditions, and age
and sex distributions were diverse. Potential bias, resulting for
instance from methodological problems, differences in age of
the people surveyed, interobserver error, and so on, would cer-
tainly have influence the survey results. However, the key pro-
cedure in estimating disease prevalence was similar for all of
these surveys, which included medical interview, physical
examination and relating laboratory/radiographic examina-
tions. Furthermore, the diagnostic criteria for the diseases con-
sidered were all generally acceptable. The major difference
between studies employing the COPCORD protocol and the
other studies was that the former included additional informa-
tion related to the burden of disease, intervention and aetiol-
ogy of disease. Most surveys included here aimed to assess
prevalence rates of different rheumatic diseases, with a few
including an evaluation of risk factors.
Table 6
Prevalence of hyperuricemia and gout in China
Site of survey [ref.] Location Age (Years) Time Number Hyperuricaemiaa (%) Gout (%)
Four cities [5] Urban ≥20 1980 502 M 1.4/F 1.3 0
Beijing [11] Urban 40 to 58 1988 2,013 M 15.4/F 11.3
Beijing [11] Rural 40 to 58 1988 1,507 M 11.0/F 8.4
Qingdao [36] Urban ≥20 2002 2,023 M 32.1/F 21.8 0.36
Nanjing [37] Urban ≥20 2003 7,888 M 13.8/F 6.1 0.67
Shanghai [26] Urban ≥15 1997 2,037 M 14.2/F 7.1 0.34
Taiwan [24] Island ≥19 1996 5,707 M 42.1/F 27.4 1.98
Taiwan [22] mountain ≥18b 1994 342 M 53.8/F 30.7 11.7
Taiyuan [41] Urban ≥16 2004 3,915 0.15
Shanghai [3] Urban ≥16 1992 2,010 0.2
Shanghai [28] Urban ≥15 1998 6,584 0.22
Shantou [17] Urban ≥16 1992 1,722 0.17
Shantou [23] Urban ≥16 1995 2,040 0.15
Shantou [29] Urban ≥16 1999 1,818 0.26
Taiwan [19] Urban ≥20 1992 3,000 0.67
Taiwan [19] Suburban ≥20 1992 3,000 0.67
Taiwan [19] Rural ≥20 1992 2,998 0.16
aMale (M) ≥ 7.0 mg/dl, female (F) ≥ 6.0 mg/dl. bAborigines.Arthritis Research & Therapy    Vol 10 No 1    Zeng et al.
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Prevalence rates of rheumatic pain reported from Australia,
Bangladesh, India, Indonesia, Philippines, Thailand and Viet-
nam were 33%, 26.3%, 18.2%, 23.6% to 31.3%, 16.3%,
36.2% and 14.9%, respectively [56-62], indicating variation
by locality, methods of survey, definition of disease categories
and ethnic group. As shown in Table 2, there was a trend for
the rate of positive response in the general population to a
questionnaire relating to rheumatic complaints to increase
with increasing latitude in locality. In Malaysian Chinese living
at 5° north latitude, the prevalence of rheumatic complaints
was only 13% in a 1992 survey [63]. Furthermore, in the Shan-
tou area it was shown that after the 1980s, following growing
economic development, there was a trend toward increased
prevalence of rheumatic pain [42]. It is thus of importance to
investigate how socioeconomic status, environmental differ-
ences, sex, age, occupation, ergonomics, bone mineral den-
sity and awareness of seeking medical care influence the
prevalence of rheumatic complaints.
The prevalence of symptomatic OA varied widely with locality
and population. In China the prevalence of OA ranged from
5.1% to 20.8%, with a mean of 9.1%. This was close to that
reported in the other Asia Pacific countries such as Australia
[56], Thailand [61], Vietnam [62], India [64] and Philippines
[65] (5.5%, 11.3%, 4.1%, 5.8% and 4.1%, respectively). It is
notable that in coal miners the prevalence was as high as
20.8% [10] (Table 3). Although the prevalence of hip OA was
very low in Chinese as compared with UK and US Caucasians
[32], the prevalence of hip OA was higher among the Chinese
coal miners [10] (2.0%) than in the general population, as was
found in UK miners by Lawrence [66]. This is apparently
related to the heavy physical labour of the miners. In elderly
Chinese males the prevalence of knee OA was comparable to
that in Caucasians, but for elderly Chinese women the preva-
lence of knee OA was higher than in Caucasian women
[34,67]. In 1995 Zeng and colleagues [68] reported that, in
both clinical and epidemiological studies, the prevalence of
symptomatic hand OA in Shantou, China (0.4%) was markedly
lower in Chinese than in Caucasians. Reports from Hebei in
1988 [10] and Taiyuan in 2004 [39], and a cooperative Chi-
nese-American study of hand OA (the ratio of hand OA preva-
lence in China to that in the USA was 0.25%, after adjustment
for age) [33], further enhanced the impression that the preva-
lence of hand OA was indeed lower in Chinese than in
Caucasians.
In China, the prevalence of AS among the Han ethnic popula-
tion (0.2% to 0.54%) was close to that in Caucasians [69,70]
but higher than that in Thailand (0.12%) [61]. However,
among mixed ethnic populations such as Manchu and Han or
Muslin and Han, the prevalence of AS (about 0.1%) was lower
than that in the Han ethnic group. Although HLA-B27 was not
investigated in these surveys, these findings once again sug-
gest that genetic factors are associated with AS. Further study
including HLA-B27 tests in individual minority ethnic popula-
tions is necessary to confirm these findings. uSpA was a fre-
quently neglected form of spondylopathy. The prevalence of
uSpA ranged from 0.64% to 1.21% in the Han ethnic group,
even higher than that of frank AS, which challenges clinicians
to improve their diagnostic awareness of uSpA.
The prevalence of RA in mainland China, ranging from 0.2% to
0.37%, was similar to that in most Asian countries
[60,61,64,65,71] and South American countries [72,73] but
lower than that in Caucasians [74]. In Taiwan urban and sub-
urban areas, the prevalence of RA (0.93%) was closer to rates
in Caucasians, but the prevalence of 0.26% in a Taiwan rural
area was similar to that in mainland China. This might be
accounted for by the fact that Taiwan urban areas were more
developed than in mainland China. Apart from genetic factors,
environmental and socioeconomic factors might be important
risk factors for RA; this possibility awaits further study.
For some time, hyperuricaemia and gout were thought to be
rare in China [5]. Since the 1980s it has become apparent that
the prevalence of hyperuricaemia has exhibited a trend toward
increased prevalence in both men (from 11.0% to 32.1%) and
women (from 6.1% to 21.8%). Among Taiwan aborigines, the
high rates of hyperuricaemia of 53.8% in men and 30.7% in
women are remarkable. In mainland China, the prevalence of
gout (0.15% to 0.67%) is lower than in Austronesians
(Malayo-Polynesians) [75,76], Caucasians [77] and Austral-
ians [56], and slightly higher than in some other Asia countries
such as Thailand, Vietnam and India (0.16%, 0.14% and
0.12%, respectively) [61,62,64]. Data from the USA showed
that the overall prevalence of gout had doubled from 1969 to
1986 [78]. This trend toward a general increase indicates that
living in affluent populations, and consequent changes in die-
tary habits and lifestyle are the main risk factors for gout.
Improvement in diagnostic measures for gout may also play a
role.
Prevalence of soft tissue rheumatism (2.5% to 5.7%) in China
was close to that in some Asian countries such as Bangladesh
(2.5%) [57] and Philippines (3.8%) [60]. Fibromyalgia was
rarely observed in China, with a prevalence of 0.05 % (3/
6,265), which was distinctly lower than in reports from other
parts of the world [57,79]. Veerapen reported from Malaysia in
1992 [63] that the prevalence of fibromyalgia was higher
among Indian than among Malay, and lowest among Chinese.
This was in accordance with the situation in mainland China.
Buskila and coworkers [80] claimed that fibromyalgia was
associated with genetic factors. Whether the low prevalence
of fibromyalgia in China has any genetic explanation awaits fur-
ther study.
Many population surveys of the prevalence of SLE have been
conducted in China [81]. The minimum sample size required is
considered to be 30,000. In the Guangzhou and Shandong
surveys the prevalence rates were 0.031% (8/25,692) andAvailable online http://arthritis-research.com/content/10/1/R17
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0.053% (9/17,044), yielding a combined prevalence of
0.036% (17/46,736), which is similar to US Caucasian prev-
alence rates, which range from 0.0146% to 0.124% [82]. The
Shanghai survey of textile factory workers revealed a higher
prevalence at 0.07% (23/32,626). There was a higher propor-
tion of women to men in the Shanghai survey (1.6:1), and so
the population prevalence would have been overestimated.
The factory workers might have been exposed to risk factors
that are specific to that environment, such as chemical
exposure.
The only survey of primary Sjögren's syndrome suggested that
it was not rare in China, but many cases had previously been
overlooked or misdiagnosed.
Conclusion
Rheumatic diseases are common in China. Prevalence of
rheumatic symptoms increases with latitude and varies with
the locality and age. The prevalence of OA was comparable
with that in Western countries but exhibited variance in joint
distribution; the highest rates for hip and knee OA were in coal
miners. The prevalence of AS in China was similar to that in
Caucasians and similarly related to HLA type. The prevalence
of RA was lower than that in the developed countries except
in a more developed Taiwan urban area. The prevalence of
hyperuricaemia has increased since 1990. Although the prev-
alence of gout was lower than in the developed countries,
there has been a trend toward increased prevalence in China
in recent years. Fibromyalgia was rarely seen in China. China
includes a vast territory with more than 50 ethnic groups. Most
minority groups live in the west and northwest parts of China.
Paying more attention to the epidemiology of rheumatic dis-
eases in these areas is of great importance.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
QYZ participated in the design and prepared the manuscript,
and took part in the ILAR-China study and WHO ILAR-APLAR
COPCORD Shantou, Beijing, Taiyuan study. RC and ZYX par-
ticipated in the design, and took part in the ILAR-China study
and WHO ILAR-APLAR COPCORD Shantou, Beijing, Taiy-
uan study. SBC took part in the data collection, performed the
statistical analyses and helped to prepare the manuscript. JD
and RW participated in the design, helped to finalize the
manuscript, were the supervisors of the WHO ILAR-APLAR
COPCORD study, and took part in the ILAR-China study and
WHO ILAR-APLAR COPCORD Shantou, Beijing study. SLC
and NZZ directed the ILAR-China study and WHO ILAR-
APLAR COPCORD study, respectively, and helped to pre-
pare the manuscript. All authors read and approved the final
manuscript.
Acknowledgements
This work was supported in part by grants from the ILAR, APLAR and 
Science Foundations of the Department of Education, the Department 
of Health of Guangdong, China.
References
1. Muirden KD: Rheumatic diseases in China.  J Rheumatol 1994,
21:1383-1384.
2. Zhang NZ: A Resume of epidemiological surveys of several
main rheumatic diseases in China.  Chin Med J 1998,
111:195-196.
3. Chen SL, Zeng QY: The COPCORD study in China [abstract].  In
Programme and Abstracts of the 8th Asia Pacific League of Asso-
ciations for Rheumatology Congress of Rheumatology Melbourne,
Australia:s182.  21–26 April 1996
4. Beasley RP, Bennett PH, Lin CC: Low prevalence of rheumatoid
arthritis in Chinese. Prevalence survey in a rural community.  J
Rheumatol 1983:11-15.
5. Fang Q, Chen HZ, Yu ZF, Huang BJ, Yu CH: Survey of uric acid
among healthy Chinese and its relation to blood lipid.  Chin J
Intern Med (Chinese) 1983, 22:434-438.
6. Sun G, Xia D, Fang H: A survey of incidence of rheumatoid
arthritis (RA) and ankylosing spondylitis (AS).  Chin J Rehabil
Med (Chinese) 1988, 3:115-117.
7. Huang M, Chen S, Lu G, Wang W, Jiang S, Zhang L, Jin W, Yu J,
Xu S, Cai Y, et al.: Epidemiological survey on systemic lupus
erythematosus.  Chin J Intern Med (Chinese) 1985,
24:451-453.
8. Zeng QY, Huang S, Zhou X, Li D, Chen W, Xiao Z, Li X, Xu J: Pop-
ulation and family survey of ankylosing spondylitis with HLA-
B27 determinations.  Chin J Intern Med (Chinese) 1987,
26:387-389.
9. Wigley RD, Zhang NZ, Zeng QY, Shi CS, Hu DW, Couchman K,
Duff IF, Bennett PH: Rheumatic diseases in China: ILAR-China
study comparing the prevalence of rheumatic symptoms in
northern and southern rural populations.  J Rheumatol 1994,
21:1484-1490.
10. Yang L, Guo J, Lin H: Investigation on osteoarthropathy in 1000
coal miners.  Chin J Trad Med Traum Ort (Chinese) 1989,
5:10-13.
11. Li Y, Stamler J, Xiao Z, Folsom A, Tao S, Zhang H: Serum uric acid
and its correlate in Chinese adult population, urban and rural,
of Beijing. The PRC-USA Collaborative Study in Cardiovascu-
lar and Cardiopulmonary Epidemiology.  Int J Epidemiol 1997,
26:288-296.
12. Zhang F, Zhao Y, Ren X: Report on survey of rheumatic dis-
eases in northern very cold area of China.  Rheum Dis Integrat
Chin Trad Med Moden Med (Chinese) 1992, 1:1-4.
13. Xu D, Li B, Chen H, Ruan Z, Zeng Y, Yang X: Epidemiological
study of systemic lupus erythematosus in Guangzhou area.
Chin J Dermatol (Chinese) 1992, 25:50-52.
14. Qian L, Chen J, He L, Liu R, Dong G: An epidemiological survey
and analysis on the rheumatic diseases among peasants in
Ningxia frigid high elevation region.  Environ Sci (Chinese)
2001:107-109.
15. Xu JC, Chen R, Xu LD, Li XJ, Huang SB, Xiao ZY, Xie SH, Zhou
XG, Zeng QY: An investigation of the causal factors of the
higher prevalence rate of joint complain in the north than
south.  J Shantou Univ Med Coll (Chinese) 1993, 2:50-52.
16. Chen R, Xu LD, Xu JC, Li XJ, Zhou XG, Xiao ZY, Huang SB, Xie
SH: Population study of symptomatic osteoarthritis.  J Shantou
Univ Med Coll (Chinese) 1993, 2:54-56.
17. Zeng QY, Zhou XG, Xiao ZY, Huang SB, Xie SH, Xu LD, Chen R,
Xu JC, Li XJ: BMD of distal radius and gout in the population of
middle schools in Chenghai downtown.  J Shantou Univ Med
Coll (Chinese) 1993, 6:46-49.
18. Lau E, Symmons D, Bankhead C, Macgregor A, Donnan S, Silman
A: Low prevalence of rheumatoid arthritis in the urbanized
Chinese of Hong Kong.  J Rheumatol 1993, 20:1133-1137.
19. Chou CT, Pei L, Chang DM, Lee CF, Schumacher HR, Liang MH:
Prevalence of rheumatic diseases in Taiwan: a population
study of urban, suburban, rural differences.  J Rheumatol 1994,
21:302-306.Arthritis Research & Therapy    Vol 10 No 1    Zeng et al.
Page 10 of 11
(page number not for citation purposes)
20. Zhang N, Shi Q, Zhang X, Sha L, Wang Y, Zhao S, Lu S, Yu G, Qu
H: An epidemiological study of knee osteoarthritis.  Chin J
Intern Med (Chinese) 1995, 34:84-87.
21. Zhang NZ, Shi CS, Yao QP, Pan GX, Wang LL, Wen ZX, Li XC,
Dong Y: Prevalence of primary Sjögren's syndrome in China.  J
Rheumatol 1995, 22:659-661.
22. Chou CT, Lai JS: The epidemiology of hyperuricemia and gout
in Taiwan aborigines.  Br J Rheumatol 1998, 37:258-262.
23. Zeng QY, Chen R, Xiao ZY, Liu Y, Xu J, Wigkey RD: Shantou
COPCORD study: stage I.  APLAR Bull 1995, 13:74-76.
24. Chang H, Pan W, Yeh W, Tsai K: Hyperuricemia and gout in Tai-
wan: results from the Nutritional and Health Survey in Taiwan
(1993–1996).  J Rheumatol 2001, 28:1640-1646.
25. Zhang H, Liu Z, Su H, Zhou H, Xun Y, Jiang X: Epidemiological
studies on rheumatoid arthritis and ankylosing spondylitis in
rural area of Shandong province.  Chin J Rheumatol (Chinese)
1998, 2:85-87.
26. Chen S, Du H, Wang Y, Xu L: The epidemiology study of hype-
ruricemia and gout in a community population of Huangpu
District in Shanghai.  Chin Med J 1998, 111:228-230.
27. Jiang B, Zhang Y, Xu X, Mei H, Wang G, Ding F, Ding Z: A preva-
lence study of rheumatic diseases in eastern coastline of
Shandong province.  Acta Acad Med Shandong (Chinese)
2001, 39:210-211.
28. Dai S, Han X, Zhao D, Shi Y, Liu Y, Meng J: Prevalence of rheu-
matic symptoms, rheumatoid arthritis, ankylosing spondylitis,
and gout in Shanghai, China: a COPCORD study.  J Rheumatol
2003, 30:2245-2251.
29. Zeng QY, Wang Q, Chen R, Xiao Z, Huang S, Xu J: Primary gout
in Shantou: a clinical and epidemiological study.  Chin Med J
2003, 116:66-69.
30. Chen R, Wang Q, Lin Q, Wu X, Xu J, Xie S, Zeng QY: Epidemio-
logical study of seronegative spondyloarthropathies.  Chin J
Rheumatol (Chinese) 2000, 4:240-241.
31. Chen R, Du L, Lin Q, Chen S, Lin L, Xu J, Xie S: Epidemiological
study of seronegative spondyloarthropathies in Beijing area.
Chin J Prim Med Pharm (Chinese) 2002, 9:593-594.
32. Nevitt MC, Xu L, Zhang Y, Lui L, Yu W, Lane NE, Qin M, Hochberg
MC, Cummings SR, Felson DT: Very low prevalence of hip oste-
oarthritis among Chinese elderly in Beijing, China, compared
with Whites in the United States.  Arthritis Rheum 2002,
46:1773-1779.
33. Zhang Y, Xu L, Nevitt MC, Niu J, Goggins JP, Aliabadi P, Yu W, Lui
LY, Felson DT: Lower prevalence of hand osteoarthritis among
Chinese subjects in Beijing compared with white subjects in
the United States: the Beijing Osteoarthritis Study.  Arthritis
Rheum 2003, 48:1034-1040.
34. Zhang Y, Xu L, Nevitt MC, Aliabadi P, Yu W, Qin M, Lui LY, Felson
DT:  Comparison of the prevalence of knee osteoarthritis
between the elderly Chinese population in Beijing and whites
in the United States: the Beijing Osteoarthritis Study.  Arthritis
Rheum 2001, 44:2065-2071.
35. Cao T, Huang H, Duan Y, Ji Y, Chen L, Dong D, Li H, Wang B,
Zhang G: Epidemiological study of ankylosing spondylitis of
the men of military officers and soldiers in Northeast Military
Region.  Chin J Rheumatol (Chinese) 2000, 4:307-308.
36. Nan H, Qiao Q, Dong Y, Gao W, Tang B, Qian R, Tuomilehto J:
The prevalence of hyperuricemia in a population of the coastal
city of Qingdao, China.  J Rheumatol 2006, 33:1346-1350.
37. Shao J, Mo B, Yu R, Li Z, Liu H, Xu Y: Epidemiological study on
hyperuricemia and gout in community of Nanjing.  Chin J Dis
Control Prev (Chinese) 2003, 7:305-308.
38. Du H, Chen S, Bao C, Wang X, Lu Y, Gu Y, Xu J, Chai W, Chen J,
Nakamura H, et al.: Prevalence and risk factors of knee osteoar-
thritis in Huang-Pu District, Shanghai, China.  Rheumatol Int
2005, 25:585-590.
39. Zang C, Zeng QY, Li X, Dong H, Zhang A: Epidemiological study
of osteoarthritis in Taiyuan.  Shanxi Med J (Chinese) 2006,
35:767-770.
40. Dong H, Zang C, Zhang A, Zheng J: Epidemiological study of
seronegative spondyloarthropathies in Taiyuan.  Chin Reme-
dies Clinics (Chinese) 2006, 6:262-265.
41. Zang CH, Zeng QY, Li X, Dong H, Zhang A: Epidemiological
study of rheumatic diseases in Taiyuan area.  Chin Remd Clin
(Chinese) 2007, 7:597-602.
42. Zeng QY, Darmawan J, Xiao ZY, Chen SB, Chen R, Lin K, Wigley
R, Chen SL, Zhang NZ: Risk factors associated with rheumatic
complaints: a WHO-ILAR COPCORD study in Shantou, south-
east China.  J Rheumatol 2005, 32:920-927.
43. Zhang G, Yang Y, Feng Z, Zhang Y, Feng M, Ji Y, Lu Q, Ma J, Ji Y,
Mao X, et al.: Report of HLA distribution of Chinese Bone Mar-
row Bank (Shanghai).  Chin J Organ Transplant (Chinese) 2001,
22:179-185.
44. Song Y, Zhu C, Lv H, Rong Z, Nie X, Wang M, Liu Y: HLA-A, B,
DRB1 gene distribution of Shandong Han ethnic population
bone marrow bank.  Chin J Blood Transfus (Chinese) 2005,
18:327-329.
45. Deng Y, Yang G, Wu D, Hu S, Li S, Zhu J, Zhu B, Liu Y: HLA-A, B,
DRB1 gene polymorphism of Beijing population was studied
by high-resolution polymerase chain reaction sequence-
based typing.  Chin J Med Genet (Chinese) 2006, 23:103-106.
46. Wu G, Deng Z, Gao S, Cheng L, Jin S, Zhou D, Li Z, Zhou H,
Zhang X, Wei T, et al.: Study of HLA polymorphism in the 6965
Han bone marrow registry donors.  Chin J Hematol (Chinese)
2004, 25:473-477.
47. Dai Q, Huang Y: Significance of HLA-B27 determination in the
diagnosis of ankylosing spondylitis.  Occupation Health
(Chinese) 2006, 22:2005-2006.
48. Liu H: HLA-B27 in ankylosing spondylitis patients in Yuxi area.
Shandong Med J (Chinese) 2006, 46:69-70.
49. Lin J, Lv H, Chen Z, Jiang D, Wang S, Feng C: Ankylosing spond-
ylitis and HLA-B27 subtypes: a disease related research in
Chinese Han nationality.  J Beijing Med Univ (Chinese) 1994,
26:323-326.
50. Lin J, Lv H, Feng C: Ankylosing spondylitis and heterogenity of
HLA-B27 in Chinese.  Chin J Surg (Chinese) 1996, 34:333-335.
51. Jiang L, Fan L, Yang J, Yao F, Zhou J, Xu R, Gao P: Study on anky-
losing spondylitis and HLA-B27 alleles.  Chin J Immunol
(Chinese) 1997, 13:345-348.
52. Yang G, Deng Y, Yan C, Wu D, Hu S, Zhu B, Li S, Zhang X, Liu Y:
Frequencies distribution of human leukocyte antigen-B27
subtypes in healthy Chinese.  Acta Acad Med Sin (Chinese)
2006, 28:240-243.
53. Huang F, Zhao H, Shi G: Family surveys of 5 cases of
spondyloarthropathies.  Chin J Intern Med (Chinese) 1994,
33:44-45.
54. Cai Q, Han X, Chen R, Yang B, Zhao F: Family aggregation of
ankylosing spondylitis.  Chin J Rheumatol (Chinese) 2003,
7:668-672.
55. Yang X, Tang F, Yin P: The trend of proportion among inpatients
with gout in 21 hospitals during the past 15 years.  Chin J Epi-
demiol (Chinese) 1996, 17:10-12.
56. Minaur N, Sawyers S, Parker J, Darmawan J: Rheumatic disease
in an Australian Aboriginal community in North Queensland,
Australia. A WHO-ILAR COPCORD survey.  J Rheumatol 2004,
31:965-972.
57. Haq SA, Darmawan J, Islam MN, Uddin MZ, Das BB, Rahman F,
Chowdhury MAJ, Alam MN, Mahmud TAK, Chowdhury MR, et al.:
Prevalence of rheumatic diseases and associated outcomes
in rural and urban communities in Bangladesh: a COPCORD
study.  J Rheumatol 2005, 32:348-353.
58. Chopra A, Saluja M, Patil J, Tandale HS: Pain and disability, per-
ceptions and beliefs of a rural Indian population: a WHO-ILAR
COPCORD study.  J Rheumatol 2002, 29:614-621.
59. Darmawan J, Valkenburg HA, Muirden KD, Wigley RD: Epidemiol-
ogy of rheumatic diseases in rural and urban populations in
Indonesia.  Ann Rheum Dis 1992, 51:525-528.
60. Dans LF, Tankeh-Torres S, Amante CM, Penserga EG: The prev-
alence of rheumatic diseases in a Filipino urban population: a
WHO-ILAR COPCORD study.  J Rheumatol 1997,
24:1814-1819.
61. Chaiamnuay P, Darmawan J, Muirden KD, Assawatanabodee P:
Epidemiology of Rheumatic disease in rural Thailand: a WHO-
ILAR COPCORD study.  J Rheumatol 1998, 25:1382-1387.
62. Minh Hoa TT, Darmawan J, Chen SL, Van Hung N, Thi Nhi C, Ngoc
An T: Prevalence of the rheumatic diseases in urban Vietnam:
a WHO-ILAR COPCORD study.  J Rheumatol 2003,
30:2252-2256.
63. Veerapen K: Epidemiology of rheumatic disease in Malaysia.
APLAR Rheumatology. Edited by Nasution R. London, UK:
Churchill Livingstone 1992:397-399.
64. Chopra A, Patil J, Billempelly V, Relwani J, Tandle HS: Prevalence
of rheumatic diseases in a rural population in western India: aAvailable online http://arthritis-research.com/content/10/1/R17
Page 11 of 11
(page number not for citation purposes)
WHO-ILAR COPCORD study.  J Assoc Physicians India 2001,
49:240-246.
65. Wigley R, Manahan L, Muirden KD, Caragay R, Pinfold B, Couch-
man KG, Valkenburg HA: Rheumatic disease in a Philippine vil-
lage. II: a WHO-ILAR- APLAR COPCORD study, phases II and
III.  Rheumatol Int 1991, 11:157-161.
66. Lawrence JS: Occupational aspects of the rheumatic diseases.
In Rheumatism in Populations Edited by: Lawrence JS. London,
UK: William Heinemann Medical Books Ltd; 1977:466-493. 
67. Felson DT, Zhang Y: An update on the epidemiology of knee
and hip osteoarthritis with a view to prevention.  Arthritis
Rheum 1998, 41:1343-1355.
68. Zeng QY, Huang S, Xiao Z, Chen S, Liu X, Zhou X: Osteoarthritis:
clinical and epidemiological investigation.  Chin J Intern Med
(Chinese) 1995, 34:88-90.
69. Carter ET, McKenna CH, Brian DD, Kurland LT: Epidemiology of
ankylosing spondylitis in Rochester, Minnesota: 1935–1973.
Arthritis Rheum 1979, 22:365-370.
70. Gran JT, Husby G, Hordvik M: Prevalence of ankylosing spond-
ylitis in males and females in a young middle aged population
of Tromso, Northern Norway.  Ann Rheum Dis 1985,
44:359-367.
71. Darmawan J, Muirden KD, Valkenburg HA, Wigley RD: The epide-
miology of rheumatoid arthritis in Indonesia.  Br J Rheumatol
1993, 32:537-540.
72. Senna ER, De Barros ALP, Silva EO, Costa IF, Pereira LVB,
Ciconelli RM, Ferraz MB: Prevalence of rheumatic diseases in
Brazil: a study using the COPCORD approach.  J Rheumatol
2004, 31:594-597.
73. Cardiel MH, Rojas-Serrano J: Community based study to esti-
mate prevalence, burden of illness and help seeking behavior
in rheumatic diseases in Mexico City. a COPCORD study.  Clin
Exp Rheumatol 2002, 20:617-624.
74. Silman A, Hochberg MC, (editors): Epidemiology of the Rheu-
matic Diseases Oxford, UK: Oxford University Press; 1993:16-20. 
75. Darmawan J, Valkenburg HA, Muirden KD, Wigley RD: The epide-
miology of gout and hyperuricemia in a rural population of
Java.  J Rheumatol 1992, 19:1595-1599.
76. Darmawan J, Lutalo SK: Gout and hyperuricaemia.  Baillieres
Clin Rheumatol 1995, 9:83-94.
77. Harris CM, Lloyd DCEF, Lewis J: The prevalence and prophy-
laxis of gout in England.  J Clin Epidemiol 1995, 48:1153-1158.
78. Lawrence RC, Hochberg MC, Kelsey JL, Mcduffie FC, Medsger
TA, Felts WR, Shulman LE: Estimates of the prevalence of
selected arthritic and musculoskeletal diseases in the United
States.  J Rheumatol 1989, 16:427-441.
79. Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L: The prevalence
and characteristics of fibromyalgia in the general population.
Arthritis Rheum 1995, 38:19-28.
80. Buskila D, Sarzi-Puttini P: Biology and therapy of fibromyalgia.
Genetic aspects of fibromyalgia syndrome.  Arthritis Res Ther
2006, 8:218.
81. Xu KF: Systemic lupus erythematosus in Chinese populations.
APLAR Bull 1995, 13:70-74.
82. Petri M: Epidemiology of systemic lupus erythematosus.  Best
Pract Res Clin Rheumatol 2002, 16:847-858.